Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Hefty Price Set on a New Drug that can Stunt Muscle Disease cover art

Hefty Price Set on a New Drug that can Stunt Muscle Disease

Preview
Get this deal Free with 30-day trial
Offer ends on 28 December, 2026.
Prime logo
Only ₹5/month for first 3 months.
Get 1 credit per month to use on any title of your choice.
Listen to anything from the Plus Catalogue—thousands of audiobooks, podcasts, and Audible Originals.
₹199/month after first 3 months. Cancel anytime. Renews automatically. Offer ends 28 December, 2026.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199.00 per month after 30-day trial. Cancel anytime.

Hefty Price Set on a New Drug that can Stunt Muscle Disease

Written by: Katie Thomas
Narrated by: Mike DelGaudio
Free with 30-day trial Free with 30-day trial

₹199.00 per month after 30-day trial. Cancel anytime.

₹199.00 per month after 30-day trial. Cancel anytime.

Buy Now for ₹152.09

Buy Now for ₹152.09

About this listen

The Food and Drug Administration has approved the first drug to treat patients with spinal muscular atrophy, a savage disease that, in its most severe form, kills infants before they turn 2.

"Hefty Price Set on a New Drug that can Stunt Muscle Disease" is from the December 30, 2016 Financial section of The New York Times. It was written by Katie Thomas and narrated by Mike DelGaudio.

©2016 The New York Times News Service Division of The New York Times Company (P)2016 Audible, Inc.
Politics & Government United States World
adbl_web_anon_alc_button_suppression_t1
No reviews yet